- Home
- LAW vs FENC Comparison
LAW vs FENC Comparison
Compare LAW & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAW
- FENC
- Stock Information
- Founded
- LAW 2013
- FENC 1996
- Country
- LAW United States
- FENC United States
- Employees
- LAW N/A
- FENC N/A
- Industry
- LAW Computer Software: Prepackaged Software
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LAW Technology
- FENC Health Care
- Exchange
- LAW Nasdaq
- FENC Nasdaq
- Market Cap
- LAW 249.3M
- FENC 225.4M
- IPO Year
- LAW 2021
- FENC 2001
- Fundamental
- Price
- LAW $4.81
- FENC $8.58
- Analyst Decision
- LAW Buy
- FENC Strong Buy
- Analyst Count
- LAW 2
- FENC 2
- Target Price
- LAW $6.75
- FENC $13.00
- AVG Volume (30 Days)
- LAW 142.2K
- FENC 56.3K
- Earning Date
- LAW 08-06-2025
- FENC 08-14-2025
- Dividend Yield
- LAW N/A
- FENC N/A
- EPS Growth
- LAW N/A
- FENC N/A
- EPS
- LAW N/A
- FENC N/A
- Revenue
- LAW $148,024,000.00
- FENC $33,302,000.00
- Revenue This Year
- LAW $6.11
- FENC $0.85
- Revenue Next Year
- LAW $6.46
- FENC $55.16
- P/E Ratio
- LAW N/A
- FENC N/A
- Revenue Growth
- LAW 4.05
- FENC N/A
- 52 Week Low
- LAW $3.31
- FENC $3.96
- 52 Week High
- LAW $6.64
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- LAW 78.24
- FENC 49.73
- Support Level
- LAW $3.85
- FENC $7.93
- Resistance Level
- LAW $5.10
- FENC $9.42
- Average True Range (ATR)
- LAW 0.21
- FENC 0.53
- MACD
- LAW 0.10
- FENC 0.04
- Stochastic Oscillator
- LAW 85.60
- FENC 56.44
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.